Results 261 to 270 of about 234,996 (348)
Evaluating Sex Disparity in Pancreatic Ductal Adenocarcinoma Risk in the UK Biobank Cohort
ABSTRACT Background The incidence of pancreatic ductal adenocarcinoma (PDAC) is lower in females than males (19.0 vs. 20.2 for 100,000 individuals in Europe). This disparity is commonly attributed to differences in exposure to lifestyle risk factors such as smoking and alcohol consumption; however, hormonal activity may also play a role. Objective This
Giulia Peduzzi +6 more
wiley +1 more source
In-depth evaluation of XPR1 as a new prognostic indicator for endometrial cancer. [PDF]
Han X, Yang L, Nuermanguli R, Wang H.
europepmc +1 more source
Renal cell carcinoma with atypical omental metastasis: A case report and literature review
Abstract Background Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults, with common metastatic sites including the lungs, bones, liver, and brain. Omental metastasis is exceedingly rare and usually occurs postoperatively. Fumarate hydratase‐deficient (FH‐deficient) RCC, a recently classified and highly aggressive subtype of ...
Andrew Jing +4 more
wiley +1 more source
Impact of uterine adenomyosis on survival outcome of patients with non-endometrioid endometrial cancer. [PDF]
Ozgen L, Yalcin Y, Abay M, Ozerkan K.
europepmc +1 more source
ABSTRACT Objective To analyse prescribing trends for oral and transdermal hormone replacement therapy (HRT) in Wales from 1996 to 2023, including predictors of discontinuation within one year of initiation. Design Observational study using the Secure Anonymised Information Linkage (SAIL) databank.
Robin Andrews +3 more
wiley +1 more source
Figo stage IIIC endometrial cancer patients undergoing surgery and adjuvant radiation therapy
Kira Murphy +3 more
openalex +1 more source
Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next? [PDF]
Cripe, James C +8 more
core +1 more source
Advent of NK3R Antagonists for the Treatment of Menopausal Hot Flushes: A Narrative Review
ABSTRACT The menopause transition is marked by symptoms predominantly attributed to declining oestrogen levels. Approximately 80% of women experience associated symptoms, and 25% experience severe symptoms. The commonest are vasomotor symptoms (VMS), collectively referring to hot flushes and/or night sweats.
Aaran H. Patel +5 more
wiley +1 more source

